Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Javitt Jonathan C Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Bought 100,000 shares @ $0.33, valued at $33k
08/23/2023 4 Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Bought 200,000 shares @ $0.322, valued at $64.4k
02/14/2023 5 Javitt Jonathan C (10% Owner) has filed a Form 5 on NRX Pharmaceuticals, Inc.
12/09/2022 4 Javitt Jonathan C (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Sold 400,000 shares @ $1, valued at $400k
06/17/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
06/02/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2021 SC 13D/A Javitt Jonathan C reports a 48.2% stake in NRX Pharmaceuticals, Inc.
06/10/2021 4 Javitt Jonathan C (CEO) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 46,332 shares @ $0
Granted 13,348,997 shares @ $0
Granted 1,422,000 shares @ $0
06/10/2021 3 Javitt Jonathan C (CEO) has filed a Form 3 on NRX Pharmaceuticals, Inc.
06/03/2021 SC 13D Javitt Jonathan C reports a 60.7% stake in NRX Pharmaceuticals, Inc.
03/09/2009 4/A Javitt Jonathan C (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC
03/05/2009 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy